Robert J. Young

Active 1963–2025

243
Papers
42,649
Citations
105
h-index
230
i10-index

Citations

Citations per year for Robert J. Young1905: 2 citations1965: 1 citations1967: 1 citations1968: 1 citations1969: 1 citations1973: 1 citations1974: 3 citations1975: 1 citations1977: 1 citations1979: 2 citations1980: 2 citations1981: 1 citations1984: 4 citations1985: 12 citations1986: 14 citations1987: 19 citations1988: 13 citations1989: 10 citations1990: 20 citations1991: 17 citations1992: 26 citations1993: 20 citations1994: 16 citations1995: 27 citations1996: 25 citations1997: 27 citations1998: 41 citations1999: 38 citations2000: 35 citations2001: 48 citations2002: 62 citations2003: 80 citations2004: 78 citations2005: 75 citations2006: 93 citations2007: 122 citations2008: 105 citations2009: 127 citations2010: 134 citations2011: 148 citations2012: 184 citations2013: 234 citations2014: 219 citations2015: 231 citations2016: 232 citations2017: 286 citations2018: 283 citations2019: 738 citations2020: 927 citations2021: 995 citations2022: 878 citations2023: 683 citations2024: 1,043 citations2025: 499 citations2026: 20 citations1906–1964: no citations, so these years are not shown1966: no citations, so this year is not shown1970–1972: no citations, so these years are not shown1976: no citations, so this year is not shown1978: no citations, so this year is not shown1982–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,647 citing papers, 21.3% of this breakdownChina: 1,254 citing papers, 10.1% of this breakdownUnited Kingdom: 1,222 citing papers, 9.8% of this breakdownGermany: 801 citing papers, 6.5% of this breakdownItaly: 529 citing papers, 4.3% of this breakdownFrance: 454 citing papers, 3.7% of this breakdownCanada: 393 citing papers, 3.2% of this breakdownAustralia: 376 citing papers, 3% of this breakdownNetherlands: 331 citing papers, 2.7% of this breakdownSwitzerland: 325 citing papers, 2.6% of this breakdownIndia: 318 citing papers, 2.6% of this breakdownJapan: 303 citing papers, 2.4% of this breakdown
0%21.3%Other 27.8%

Fields

  • Medicine43.7%
  • Biochemistry, Genetics and Molecular Biology12.6%
  • Computer Science11.9%
  • Materials Science8.9%
  • Engineering7.6%
  • Physics and Astronomy3%
  • Other12.3%

Topics

  • Glioma Diagnosis and Treatment5%
  • Radiomics and Machine Learning in Medical Imaging2.3%
  • Quantum Information and Cryptography2.2%
  • Brain Metastases and Treatment1.9%
  • Computational Drug Discovery Methods1.7%
  • MRI in cancer diagnosis1.7%
  • Other85.2%

Coauthors

All papers

Open in search
  1. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 650

  2. A PUF taxonomy

    Authors: , , , , - Applied Physics Reviews 2019 cited by 339

  3. Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 394

  4. Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 307

  5. Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 259

  6. Expanding the medicinal chemistry synthetic toolbox

    Authors: , , , - Nature Reviews Drug Discovery 2018 cited by 694

  7. Edible unclonable functions

    Authors: , , , , , , , - Nature Communications 2020 cited by 216

  8. Efficacy of MEK inhibition in patients with histiocytic neoplasms

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 384

  9. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE‐MRI derived biomarkers in multicenter oncology trials

    Authors: , , , , , , , , , , , , , , , , - Journal of Magnetic Resonance Imaging 2018 cited by 403

  10. Mechanical properties of graphene and graphene-based nanocomposites

    Authors: , , - Progress in Materials Science 2017 cited by 2,538

  11. The Time and Place for Nature in Drug Discovery

    Authors: , , , , , , - JACS Au 2022 cited by 96

  12. Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 142

  13. Raman spectroscopy of carbon materials and their composites: Graphene, nanotubes and fibres

    Authors: , , , - Progress in Materials Science 2023 cited by 1,006

  14. The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types

    Authors: , , , - Drug Discovery Today 2010 cited by 438

  15. Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Grommes, Adrienne Boire, Mariza Daras, Anna F. Piotrowski, Alexandra Miller, Philip H. Gutin, Timothy A. Chan, Viviane Tabar, Cameron Brennan, Marc K. Rosenblum, Lisa M. DeAngelis, Ingo K. Mellinghoff, Barry S. Taylor - Clinical Cancer Research 2019 cited by 156

  16. Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data

    Authors: , - Journal of Medicinal Chemistry 2020 cited by 120

  17. Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity

    Authors: , , , - Drug Discovery Today 2011 cited by 304

  18. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2024 cited by 72

  19. The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes

    Authors: , , , - Diabetes Care 1985 cited by 1,423

  20. Composites with carbon nanotubes and graphene: An outlook

    Authors: , , , , - Science 2018 cited by 1,051

  21. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

    Authors: , , , , , , , , , , , - Journal of Neuro-Oncology 2015 cited by 301

  22. CEST MR fingerprinting (CEST‐MRF) for brain tumor quantification using EPI readout and deep learning reconstruction

    Authors: , , , , , , - Magnetic Resonance in Medicine 2022 cited by 63

  23. The Human Fetus Preferentially Engages with Face-like Visual Stimuli

    Authors: , , , , , - Current Biology 2017 cited by 421

  24. Background, current role, and potential applications of radiogenomics

    Authors: , , , , , , , , - Journal of Magnetic Resonance Imaging 2017 cited by 182